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1. Introduction
Protozoan parasites of the genus Leishmania are responsible of a large variety of clinical
manifestations ranging from self-healing cutaneous forms (CL), through mucocutaneous
lesions (MCL), to lethal if untreated visceral disease (VL). Nevertheless, there is no absolute
correlation between a particular clinical form and a causative species [1]. For instance, parasites
of the L. donovani complex are generally responsible for VL cases in the Old and New World
but can also cause CL. Another example is the L. tropica species, which causes a CL form but
its association to VL cases was occasionally reported [2]. Identification of Leishmania parasites
is a central issue to patients’ management and to control. Leishmaniases have a worldwide
distribution but only absent in the poles regions, and in Australia where in spite of presence
of the parasites in Kangourous no human cases were described. According to the WHO, 350
million people are at risk, with a prevalence of 12 million and more than 98 countries affected
[3]. More than twenty species are responsible for leishmaniasis in humans. However, Leish‐
mania species present very similar morphologies in their flagellated, promastigote forms and
their intracellular, amastigote forms which renders necessary the use of molecular or bio‐
chemical assays for their identification and characterization (see for review [4]).
The current identification and classification of Leishmania is still based on isoenzyme typing,
using multilocus enzyme electrophoresis (MLEE) (reviewed in [5]). This approach has been
widely used for the identification of Leishmania, but several limitations were reported. Most
importantly, differences in electrophoretic profiles were shown to be due to heterozygosity at
a single nucleotide position [6–8]. Molecular studies showed also that zymodemes included
distinct DNA genotypes [7,9]. Consequently, other molecular studies do not always agree with
the classification of Leishmania by MLEE. The other limitations of MLEE are that it requires
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bulk cultures of parasites, it is time-consuming, and it can be performed only in specialized
laboratories. Therefore, alternative DNA based tools and assays are increasingly developed
and used for effective investigation and characterization of the parasites.
Indeed, the diversity of Leishmania species, their vectors and their reservoir hosts is a main
feature of leishmaniasis, so consequently the transmission cycles are very much dependent on
the environment and are very prone to changes. So not only parasite identification is needed
to establish etiology of the disease and understand the pathogeny, but knowledge of parasite
diversity and its population structure is also needed for a better understanding of eco-
epidemiology and its changing trends. For this purpose, molecular tools have been developed
to allow differentiation of Leishmania parasites at species and strain levels within environmen‐
tal or patients’ samples.
Molecular tools are based mainly on the amplification and subsequent restriction fragment
length polymorphism (PCR-RFLP) of several targets including repeated gene families and
coding and non-coding regions, or the sequence analysis of the products. Recently multilocus
sequence typing (MLST) and multilocus microsatellite typing (MLMT) were also developed
for Leishmania DNA typing. Each of these molecular markers or tools has its specific discrim‐
inatory power, advantages and drawbacks.
2. Parasite identification
2.1. Differentiation at the genus level
This is based on the amplification of the kinetoplast minicircle DNA (kDNA, about 10000
copies per cell) or the variable sequences of the small subunit ribosomal DNA genes (SSU
rDNA, 40–200 copies per cell) [10–13].
kDNA and SSU rDNA primers were initially designed for Trypanosomatids including
Leishmania, Sauroleishmania, Crithidia and Trypanosomes. They allow identification of Leish‐
mania parasites only at the generic and/ or subgeneric level. Both targets have also been used
for the development of real-time PCR assays in order to determine parasite burden in clinical
samples [14,15].
2.2. Differentiation at the species level
The ability to distinguish between Leishmania species is crucial for a correct diagnosis of the
disease as well as for making decisions regarding treatment and control measures. This is
especially useful in areas where several Leishmania species co-exist.
Numerous  PCR  approaches  have  been  published  based  on  different  coding  and  non-
coding regions in the Leishmania genome. Different targets have been used, including the
ribosomal  internal  transcribed  spacer  (ITS)  [12,16,17],  the  mini-exon  genes  [18,19],  gp63
genes [20,21], hsp70 genes [22–24] and cysteine proteinase B gene sequences (cpB) [25,26].
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2.2.1. Randomly amplified polymorphic DNA (RAPD) and anonymous markers
Randomly amplified polymorphic DNA (RAPD) technique is based on the PCR amplification
of DNA fragments using only one short primer that was arbitrarily defined and thus could be
applied to any organism without a prior knowledge on the genome [27]. Such primers
correspond to decamers having 60-70 % GC content and no self-complementary ends, thus the
number of primers that could be used is virtually unlimited. Only in few occasions, two
primers were used for Leishmania DNA analysis [28]; primers longer than 10 mers like universal
primers used in cloning technologies have been used in some instances [29–32]. A list of
selected primers used for Leishmania characterization is reported on Table 1. The RAPD
technique generates monomorphic or polymorphic banding patterns, analyzed upon electro‐
phoresis on agarose gels (or other supports) like DNA fingerprints. Given the fact that in
comparison studies absence of bands does not reflect absence of corresponding DNA fragment
in the compared DNA [33,34], the analysis is based only on Jaccard (or equivalent) distance or
Similarity index [33] that only takes into account the presence of bands. RAPD reaction is very
sensitive to reaction conditions even when variations are minor. Relaxed conditions and
particularly low annealing temperature underlie DNA amplification but concentration or
batch (quality) of DNA, reaction component, additives, brand of DNA polymerase, thermo‐
cyclers impact size range, complexity and reproducibility of the amplification profiles [33,35].
Molecular mechanisms underlying Leishmania DNA amplification was proposed to be based
mainly on DNA mutations occurring on potential priming sites, that seem to be in regions
enriched for short repeated motives [34].
Potential of RAPD and a selection of 28 primers was assessed for the discrimination between
members of the Leishmania Viannia sub-genus which have overlapping geographical distribu‐
tion in Latin America and that were difficult to distinguish by the conventional PCR using the
primers then available. The authors have identified primers able to distinguish the 4 species
(L. braziliensis, L. guyanensis, L. panamensis and L. peruviana) in a pair wise way. They also
addressed the reliability of the technique by developing a statistical measure of the variation
range of Jaccard coefficient when comparing the parasites [33].
Primer Nucleotidesequence 5'-3' References Primer
Nucleotide sequence
5'-3' References
OPA-01 CAGGCCCTTC [30,34,36,43,44] OPR-16 CTCTGCGCGT [38]
H4 (OPA-02) TGCCGAGCTG [31,41,46] OPR-20 ACGGCAAGGA [38]
C4 (OPA-04) AATCGGGCTG [41] OPU-15 ACGGGCCAGT [38]
A5, P8, (OPA-05) AGGGGTCTTG [31,38,41,48] OPU-16 CTGCGCTGGA [38]
A4, (OPA-07) GAAACGGGTG [30,31,36,41,43] OPU-02 CTGAGGTCTC [43]
OPA-08 GTGACGTAGG [28,30,31,33] ILO 509 TGGTCAGTGA [42]
OPA-09 GGGTAACGCC [31] ILO 526 GCCGTCCGA [42]
OPA-10 GTGATCGCAG [28,30,31,36,38,43,48] ILO 872 CCCGCCATCT [42]
A12 (OPA-12) TCGGCGATAG [41] ILO875 GTCCGTGAGC [41,42]
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Primer Nucleotidesequence 5'-3' References Primer
Nucleotide sequence
5'-3' References
A15 (OPA-15) TTCCGAACCC [41] ILO 876 GGGACGTCTC [42]
D10 (OPA-20) GTTGCGATCC [41] ILO 878 GTCGCGGAG [42]
D8 (OPA-16) AGCCAGCGAA [41] A5, C5 CTCACGTAGG [39,41]
OPB-01 GTTTCGCTCC [30] C6 CTGATCGCAG [41]
C (OPB-04) GGACTGGAGT [28,33,43,44] L2 CGGACGTCGC [41]
B5 (OPB-05) TGCGCCCTTC [41] H1 CGCGCCCGCT [39,41]
B6 (OPB-06) TGCTCTGCCC [41] L15996 CTCCACCATTAGCACCCAAAGC [29,32]
OPB-07 GGTGACGCAG [30,41] λg11R TTGACACCAGACCAACTGGTAAT [29,32]
OPB-08 GTCCACACGG [38,41] M13a, M13 GTAAAACGACGGCCAGT [30,33]
OPB-09 TGGGGGACTC [30,33] M13-40 F/ M13(−40) a GTTTTCCCAGTCACGAC [29,30,32]
OPB-10 CTGCTGGGAC [43,44] M13/pUC CGCCAGGGTTTTCCCAGTCACGA [31]
OPB-12 CCTTGACGCA [30,41] P53-1 ACGACAGGGCTGGTTGCCCA [32]
OPB-13 TTCCCCCGCT [33,41] PLiD2-9 CAAAAGTCCCCACCAATCCC [42]
OPB-15 GGAGGGTGTT [30,43] QG1
CCATTAGCACCCAAAG
CAGACCTCACCCTGTGG
AGC
[29,32]
A (OPB-18) CCACAGCAGT [28,30,33] TA150 ATGCGATGAGTGGTTGAG [41,42]
OPF-01 ACGGATCCTG [38] TA610 TCAACCGATTACAAACCA [42]
OPF-10 GGAAGCTTGG [43,44] UMS GGGGTTGGTGTA [31,46]
OPF-13 GGCTGCAGAA [38,43] 37 TGGATCCGGAATTTCGGCTTCACTAC [42]
OPN-13 AGCGTCACTC [38] 198 GCAGGACTGC [41]
OPN-20 GGTGCTCCGT [38] 233 CTATGCGCGC [35]
OPR-13 GGACGACAAG [38] 283 CGGCCACCGT [35,48]
OPR-14 CAGGATTCCC [38] 3301 TCGTAGCCAA [30,33]
OPR-15 GGACAACGAG [38,43,44]
Name and sequence of the primers are reported on the table as described in the references. However, for the purpose of this
work all the sequences were compared to lists provided by Operon Technologies (OP); primers thus identified are reported
within brackets. Primers presenting discrepancies were not reported.
Table 1. Selection of primers used in RAPD analyses of Leishmania parasites generating polymorphic patterns.
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We have used the RAPD technique to identify and discriminate Old World species using 57
strains from different hosts, countries and reservoirs. Six random primers were tested from
which 3 allowed to distinguish L. aethiopica, L. arabica, L. donovani, L. major, L. tropica and L.
turanica species. We have analyzed the RAPD profiles considering criteria of consistent
presence of amplified bands at the same electrophoretic presence for strains/ isolates of the
same species, and the discrimination between parasites belonging to different species. This
constitutes a simpler way to results interpretation that emphasizes on presence of consistently
amplified and discriminative bands within a profile to overcome lack of reliability of RAPD
[36]. RAPD also allowed differentiating Old World Leishmania species from the often co-
sympatric Sauroleishmania parasites [30,36].
Random amplification of polymorphic DNA has been also used alone or with other techniques
to confirm taxonomic status of parasites, for instance putative natural hybrids such as L.
braziliensis/L. panamensis hybrids isolated in Nicaragua [33] or L. braziliensis and L. panamensis/
guyanensis in Ecuador [37]. In another example, genetic analysis of Leishmania parasites in
Ecuador with MLEE and RAPD questioned the separation of L. panamensis and L. guyanensis
as distinct taxa as these tools failed to generate clearly distinct clusters of parasites [38].
The RAPD technique was also used to investigate genetic diversity within Leishmania species
or complexes in diverse settings. Causal agents of visceral leishmaniasis belong to the L.
donovani complex, which includes the species L. donovani, L. infantum, L. chagasi and L.
archibaldi [39]; however, taxonomy within this complex is controversial considering for
instance L. infantum as forming its own complex [40]. The RAPD technique has been used to
investigate intraspecific diversity of the L. donovani complex, using an initial set of 43 random
primers [41]. Like in other studies [36,42], some primers differentiated the L. donovani complex
from the other Old World taxa. Seven distinguished within the complex, differentiating in the
tested panel of DNAs, Mediterranean L. infantum from the other parasites of the complex.
Strikingly, none of the primers distinguished L. donovani, L. infantum and L. archibaldi taxa.
Geographical clustering was observed with 2 strong Indian and East African L. donovani groups
and a third Mediterranean L. infantum group in support to a previous study using RAPD in
addition to other DNA tools [39]. Distribution of other L. infantum in the dendrogram also
supports the paraphyly of L. infantum [41].
L. infantum zymodeme MON-1 has a worldwide distribution and is responsible mainly for a
form of VL. RAPD analysis contributed to describe heterogeneity within this zymodeme and
to demonstrate its polyphyletic nature [43]. The RAPD technique also highlighted geograph‐
ical structures of L. infantum in diverse settings. In [42] they have shown that 17 (out of 18)
primers tested on 33 strains isolated from diverse hosts in various Spanish regions generated
highly polymorphic RAPD patterns that grouped the parasites into two main clusters that
included parasites from central–western region in one side and from eastern Spain in the other.
This study in addition illustrated intra-zymodemic diversity and lack of correlation with the
MLEE analysis conducted on these strains, the clinical or host origin of the parasites. In another
example, 53 L. infantum isolates from VL cases and dogs originating from different endemic
regions in Brazil were analyzed with 5 RAPD primers (also used in [43]), MLMT and SSR-PCR.
RAPD analysis was shown to be the most appropriate to illustrate genetic diversity of the
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parasites. Interestingly, in spite of the homogenous genetic background the polymorphisms
observed demonstrated correlation with geographical origin [44].
In Corte Pedra, North Eastern Brazil, L. braziliensis is causing different American Tegumentary
Leishmaniasis (ATL) forms. Forty-five L. braziliensis strains isolated from patients having
different ATL forms were shown to generate with 3 primers and 4 protocols, RAPD patterns
having overall more than 80% fingerprint identity classifying the parasites into 5 clades.
Significant distribution frequency of the different clinical forms along the clades was observed.
The authors thus concluded on the suitability of the RAPD analysis of parasite strains’
variability in Corte Pedra and that in such a spatially limited population geographical isolation
precludes geographic sequestration as the mechanism for the observed genetic structures. In
addition they assumed that infection with some L. braziliensis genotypes could be accompanied
with different pathogenic mechanisms [28]. Other studies investigating L. braziliensis diversity
in Brazil with other primers also highlighted contrasted diversity extent of parasites isolated
from cutaneous leishmaniasis according to the transmission areas; parasites from Mato Grosso
[32] or from Para [29] states were more diverse than the ones in Minas Gerais. These authors
proposed that eco-epidemiology of the parasites in relation to environmental and geographical
differences could explain in part such diversity patterns. Genetic diversity using intergenic
region typing (ITSrDNA PCR-RFLP) and MLEE of L. braziliensis from diverse hosts and
geographical origins in Brazil also illustrated occurrence of geographical clusters of parasites
exerting different levels of variability; association of L. braziliensis to specific transmission
cycles likely reflecting adaptation of different parasite clones to the vector (and diversity of)
species involved in the transmission has been inferred [45].
The RAPD technique has also been used to investigate epidemiology of leishmaniases,
characterizing clinical or field isolates in diverse settings. For instance, in India the increasing
reports on drug resistance of the VL patients and the implication of L. tropica as a causal agent
of VL, also hypothesized to be a potential reason for drug unresponsiveness [2], has prompted
investigations of the causal agents of VL using various DNA tools. A first study for example
characterized by MLEE and 8 RAPD primers 15 clinical isolates collected over 20 years from
the eastern part of India from confirmed VL patients; this sample study comprised 1 PKDL
and 6 antimony unresponsive cases. All parasites proved to be L. donovani [31]. Another study
investigated with the same primers 9 other parasites isolated over the period 2006-2010 from
hospital clinics in Kolkata from confirmed VL and a PKDL cases; one parasite was similar to
L. tropica while the others were very close to L. donovani [46]. The association of L. tropica with
the disease was further confirmed in another study using ITS, ITS1 and HP70 based assays [47].
In Iran, where cutaneous leishmaniasis is highly endemic, MLEE and kDNA were used to
identify species of 565 parasites obtained from confirmed CL patients from the different
provinces of the country during the 2002–2008 period [48]; this study associated L. major mainly
to rural transmission and L. tropica to urban settings. RAPD using 3 primers allowed describing
extensive genetic heterogeneity of a random selection of 65 L. major strains across the different
transmission area and within the same foci.
In addition, RAPD technique constitutes a powerful alternative to the identification of PCR
targets and markers. RAPD markers have been exploited for the design of species or complex
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specific PCR assays like for instance a PCR that only amplifies DNA of parasites of the L.
donovani complex [34] or another that amplifies exclusively L. braziliensis [49]. Such markers
proved to be highly informative as probes or as PCR targets [34].
Randomly amplified polymorphic DNA products were used to develop markers that were
targeted to develop typing strategies. For example, RAPD products that were amplified
consistently across tested DNAs with a combination of 2 primers have been selected and
sequenced partially to design marker specific PCR primers. The resulting PCR products were
then screened for single stranded conformation polymorphisms (SSCP) and subsequently
confirmed by sequence analysis [50]. This sequence confirmed amplified region analysis
(SCAR) approach was used to differentiate 29 L. donovani strains from Sudan, Kenya, India
and China using 8 different markers. The study identified 19 unique multilocus genotypes and
a correlation between genotypes and geographical origin; SCAR markers were considered as
co-dominant for their ability to detect all possible allele combinations in a diploid organism
and as a representative random sample of neutral genetic variation in natural populations thus
constituting appropriate tools for population studies [50].
Alternatively, with the objective to identify markers and develop simple assays for the
discrimination of viscerotropic parasites encountered in Africa, we have screened 5 Operon
kits (100 primers) for reproducible profiles and a selection of 28 primers was then used to
screen for DNA markers within a panel of viscerotropic parasites from different countries in
Africa and India [51]. These primers organized the parasites according to their geographical
origin in a similar way to other studies using RAPD or other types of tools [39,41]. Some of the
differentially amplified RAPD bands obtained in our study were cloned and sequenced; their
analysis with bioinformatics tools and comparison to their respective genomic sites in L.
infantum, L. donovani and L. major genomes highlighted the markers’ association with simple
sequence repeats and microsatellites in non coding regions [51]. A selection of such markers
in L. archibaldi was used to develop simple PCR assays differentiating viscerotropic parasites,
some of which in a country–specific way [52].
Randomly amplified polymorphic DNA is highly suitable for analysis of cultured Leishmania
promastigotes but of limited interest for analysis of patients or zoonotic samples due to sample
contamination with host DNA. Its use could be however contemplated to characterize
promastigotes at the isolation step given the technique does not require large amounts of DNA
(20 ng or less). Another generally admitted drawback is the lack of reproducibility generated
by complex reactions occurring under the relaxed reaction conditions, therefore inter-
laboratory or inter-study comparison using the same primers appear difficult to achieve.
Options to overcome this drawback were the prior selection of primers of interest, or the use
of defined criteria for analysis as for example relying only on consistently observed bands
within RAPD patterns to assign the parasites to taxonomic groups [36] or using statistical tools
to assess significance of the range of distances evaluated [33]. Use of well–standardized
protocols may also help overcoming such a drawback. Although simple and having potential
for detecting variation where other techniques fail, other drawbacks of this technique could
be that bands of equal electrophoretic mobility may not be homologous [34]; identification of
allelic variants is also not possible in Leishmania. Yet, RAPD constitutes a powerful tool for the
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identification of markers and the design of PCR based assays [34, 49–52]. Diverse RAPD
Leishmania studies reached conclusions that were confirmed by other tools or alternative
studies making the RAPD approach still valuable.
2.2.2. Gp63 PCR-RFLP and sequencing analyses
Gp63 genes encode for the major metalloprotease of Leishmania, which is the most abundant
surface glycoprotein found in promastigote and amastigote forms of the parasite. GP63 protein
is encoded by a cluster of tandemly repeated genes, and has been identified as a virulence
factor in several Leishmania species. Several groups have studied the potential of gp63 as a
species discriminatory tool in Leishmania. Amplification of gp63 genes coupled with restriction
analysis (PCR-RFLP) was applied to a large number of isolates belonging to 4 species of the
subgenus Viannia, namely L. (V.) braziliensis, L. (V.) peruviana, L. (V.) guyanensis and L. (V.)
lainsoni and allowed discrimination of all the species tested [20] (Table2).
Target Primers sequences (5’–3’) Product size (bp)
Discrimination
by Refs
PCR-RFLP Seq.
kDNA
(F) Pia1: ACGAGGTCAGCTCCACTCC 100 - - [11,13]
(R) Pia2: CTGCAACGCCTGTGTCTACG - -
(F) Pia3: CGGCTTCGCACCATGCGGTG 260 - -
(R) Pia4: ACATCCCTGCCCACATACGC - -
(F) K13A : GTGGGGGAGGGGCGTTCT 120
(R) K13B: ATTTTACACCAACCCCCAGTT
(F) RV1: CTTTTCTGGTCCCGCGGGTAGG 145
(R) RV2: CCACCTGGCCTATTTTACACCA
SSU rDNA (F) R221: GGTTCCTTTCCTGATTTACG(R) R332: GGCCGGTAAAGGCCGAATAG 603 + + [10]
Gp63
(F) TDM1: GTCTCCACCGCAGACCTCACGGA
(R) TDM2: TGATGTAGCTGCCATTCACGAAG 1300 + - [20]
(F) SG1: GTCTCCACCGAGGACCTCACCGA 1300 + -
[21]
(R) SG2: TGATGTAGCCGCCCTCCTCGAAG
(F) PDD1: TCGGTGAGGTCCTCGGTGGAGAC 1700 + -
(R) PDD2: CTTCGAGGAGGGCGGCTACATCA
(F) C9F: GGCTCCCGACGTGAGTTA 1750 + -
[58](R) C1R: GGGCCCGGGCGACAGCAGCGATGACTG
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(F) C10F: GGGAAGCTTACGTACAGCGTGCAGGTG 1600, 2000 and4500 + -
(R) C1R: GGGCCCGGGCGACAGCAGCGATGACTG
ITS (F) LITSV: ACACTCAGGTCTGTAAAC(R) LITSR: CTGGATCATTTTCCGATG
1040 or
950–1100
+
+
+
+ [64,65,69]
ITS1
(F) IR1: GCTGTAGGTGAACCTGCAGCAGCTGGATCATT
(R) IR2: GCGGGTAGTCCI’GCCAAACACTCAGGTCTG 1000–1200 + - [16]
(F) LITSR: CTGGATCATTTTCCGATG
(R) L5.8S: TGATACCACTTATCGCACTT 300–350 + +
[12,13,61,6
5,82]
ITS2
(F) LGITSF2: GCATGCCATATTCTCAGTGTC
(R) LGITSR2: GGCCAACGCGAAGTTGAATTC 372–450 - + [63]
(F) L5.8SR: AAGTGCG-ATAAGTGGTA
(R) LITSV: ACACTCAGGTCTGTAAAC 720 - + [65]
ITS1and part
of ITS2
(F) LITS-MG: ATG GCC AAC GCG AAG TTG
(R) LITSR: CTGGATCATTTTCCGATG 800 - + [69]
Hsp70
PCR-G : (F) HSP70sen: GACGGTGCCTGCCTACTTCAA
(R) HSP70ant: CCGCCCATGCTCTGGTACATC 1422 + - [22,72]
PCR-F : (F) F25: GGACGCCGGCACGATTKCT
(R) R1310: CCTGGTTGTTGTTCAGCCACTC 1286 + -
[73–75]PCR-N : (F) F25: GGACGCCGGCACGATTKCT(R) R617: CGAAGAAGTCCGATACGAGGGA 593 + -
PCR-C : (F) F251: GACAACCGCCTCGTCACGTTC
(R) R991: GTCGAACGTCACCTCGATCTGC 741 + -
(F) HSP70sen: GACGGTGCCTGCCTACTTCAA
(R) HSP70ant: CCGCCCATGCTCTGGTACATC 1422 - +
[23]
(F) HSP70-F335 CACGCTGTCGTCCGCGACG
(R) HSP70-R429 AACAGGTCGCCGCACAGCTCC 113 - +
(F) HSP70-2F CTGAACAAGAGCATCAACCC
(R) HSP70-2R CTTGATCAGCGCCGTCATCAC 170 - +
(F) HSP70-F893 GTTCGACCTGTCCGGCATCC
(R) HSP70-R1005 GTGATCTGGTTGCGCTTGCC 130 - +
PCR-F : (F) HSP70-F25: GGACGCCGGCACGATTKCT
(R) HSP70-R1310: CCTGGTTGTTGTTCAGCCACTC 1286 - +
[76]PCR-T : (F) HSP70-6F GTGCACGACGTGGTGCTGGTG(R) HSP70-R1310: CCTGGTTGTTGTTCAGCCACTC 766 - +
PCR-N : (F) HSP70-F25: GGACGCCGGCACGATTKCT
(R) HSP70-R617 CGAAGAAGTCCGATACGAGGGA 593 - +
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3’UTR : (F) 70-IR-D: CCAAGGTCGAGGAGGTCGACTA
(R) 70-IR-M: ACGGGTAGGGGGAGGAAAGA 516–733 - + [77]
Mini-exon
(F) Fme: TATTGGTATGCGAAACTTCCG
(R) Rme: GAAACTGATACTTATATAGCG 220–443 + + [19,13,78]
(F) FME2: ACTTCCGGAACCTGTCTTCC (Leishmania
subgenus) or ACTTCCGGGACCCGTCTTCC (Viannia
subgenus)
(R) ME2R: CAGAAACTGATACTTATATAGCGTTA
220–443 + + [82]
Cysteine
protease B
intragenic region :
(F) CPBFOR: CGAACTTCGAGCGCAACCT
(R) CPBREV: CAGCCCAGGACCAAAGCAA
1079 + -
[83,84]
Intergenic region :
(F) PIGS1A: CCTCATTGCTTTGGTCCTGG
(R) PIGS2B: GGCGTGCCCACGTATATCGC
1600 + -
cpbEF:
(F) CGTGACGCCGGTGAAGAAT
(R) CGTGCACTCGGCCGTCTT
702–741 - - [25,85]
cpbEF:
(F) CGTGACGCCGGTGAAGAAT
(R) CGTGCACTCGGCCGTCTT
702–741 + + [26]
Leishmania cpb:
(F) LmcpbUNIF: ACGGTCTTAGCGTGCGAGTTGTG
(R) LmcpbUNIR: CAAGGAGGTCCCCTCACGCG
1440 - +
[85]
L. major cpb (variant 1):
(F) LmcpbUNIF: ACGGTCTTAGCGTGCGAGTTGTG
(R) LmcpbR: TCGTGCAGCACATGTCGCTTG
1176 - +
L. infantum cpb:
(F) cpbEF For: CGTGACGCCGGTGAAGAAT
(R) L. inf Rev: CGTTTCGTTGCTCGGGATCAT
325 - -
L. tropica cpb:
(F) LmcpbUNIF: ACGGTCTTAGCGTGCGAGTTGTG
(R) Ltro Rev: ACAGGGCCGTCAGCCCGTGGC
600 - -
L. infantum cpb:
(F) infcpbE: GTCTTACCAGAGCGGAGTGCTACT
(R) Inf2.1: ATAACCAGCCATTCGGTTTTG
278 - -
[86]L. donovani cpb:
(F) cpbF2.1: GCGGCGTGATGACCAGC
(R) Do2.1: CAATAACCAGCCATTCGTTTTTA
309 - -
(F) MATRAE2: GGCGATGGTGGAGCAGATGATCT - -
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(R) Ma4.1: CGGTTCTCGTAGCACACTTGTTG 99 (L. major)
(R) Tr4.1: CTCCCCCGTTCGGAT 100 (L. tropica)
(R) Ae2.1: AGTACGTGCACATCAGCACATGGG 154 (L.
aethiopica)
(F) V5F: GGTGATGTGCCCGAGTGCA
(R) V10R: CGTGCACATCAGCACATGGG 564 - -
(F) CpbF: GTGCGTGCGGGTCGTGC
(R) CpbR: AAAGCCCCGGACCAAAGCA 735 - - [87]
(F): Forward primer; (R): Reverse primer; Seq.: sequence analysis; Refs: references
Table 2. Overview of DNA targets, primers sequences, product sizes and the technique used to achieve discrimination
of Leishmania taxa.
Gp63 PCR-RFLP tool was also used to characterize isolates representative of the L. donovani
complex (L. infantum, L. donovani, L. archibaldi and L. chagasi), with special attention to Medi‐
terranean L. infantum from different geographical origins, in addition to representative strains
of Old World Leishmania (L. major, L. tropica and L. aethiopica) [21] (Table2). This allowed
discrimination of the 4 species of the L. donovani complex, which were quite distinct from the
outgroup. Within L. infantum, the parasites were found to be polymorphic showing a geo‐
graphical structuring [21]. Sequences of the gp63 genes were explored in 33 strains of the L.
donovani complex having different origins and zymodemes, in addition to reference strains of
other Old World species [53]. Evolution of the gp63 multigene family was inferred to be under
the influence of a mosaic or fragmental gene conversion mechanism. The sequences clustered
according to the species, showing a concerted evolution of the different gene classes. Phylo‐
genetic analyses confirmed the genetic diversity of the L. donovani complex, which showed
that gp63 genes could provide the basis for rapid and reliable genotyping of strains in this
complex [53].
Furthermore, still using gp63 coding sequences PCR-RFLP evaluated intra-specific polymor‐
phism of L. infantum isolates in Tunisia [54]. In total, 22 L. infantum isolates responsible of
visceral (14 isolates) and cutaneous (8 isolates) forms of leishmaniasis in Tunisia were analysed,
in addition to reference isolates, representative of Old World complexes. The SalI, HincII, BalI
and BsiEI restriction enzymes were used in this intragenic gp63 PCR-RFLP analysis. Results
showed profiles that allowed distinction of L. infantum from the other species belonging to the
L. donovani complex (L. donovani, L. archibaldi and L. chagasi) but also from the Old World species
L. major, L. tropica and L. aethiopica. Besides, polymorphic patterns were observed among L.
infantum isolates that tend to be correlated to the clinical presentation of the disease; the
phenetic analysis using a UPGMA clustering method (Phylip package) grouped all VL isolates
together while most of the CL parasites clustered in a separate branch. Good bootstrapping
values supported the clusters [54].
The gp63 PCR-RFLP method was applied to characterise parasites contained within the lesions
of patients having cutaneous leishmaniasis, originating from areas in central Tunisia, known
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to be free of CL. This analysis confirmed assignment of the parasites to the L. infantum species,
thus demonstrating the occurrence/emergence of sporadic cutaneous leishmaniasis (SCL) due
to L. infantum in central Tunisia [55].
The  gp63  PCR  associated  to  RFLP  analysis  was  also  used  to  characterise  transmitted
Leishmania  in  Sudan.  Patients  that  presented  with  uncommon  cutaneous  leishmaniasis,
including one case with a L. tropica like-lesion, were confirmed, using this tool, to be infected
by  L.  major  [56].  In  another  study,  Leishmania  parasites  from  Sudanese  patients  having
cutaneous ulcers were analyzed by gp63 PCR-RFLP and shown to belong to the L. donovani
species [56]. This work allowed concluding that, in addition to L. major, L. donovani species
can also be a major cause of CL in Sudan [57].
Another PCR-RFLP analysis of the gp63 intergenic region was also developed and tested on
the L. donovani complex [58]. The markers generated robust and congruent phylogenies,
identifying 5 genetic clusters within L. donovani complex. Furthermore, clusters strongly
correlated with isoenzyme typing and some with geographical origin, which may be important
for epidemiological and clinical studies [58].
Although the gp63 PCR RFLP technique has been successfully used for Leishmania discrimi‐
nation at the species and strains levels, it presents several disadvantages. The fragment
patterns obtained are sometimes vey complex and can be difficult to analyze and compare
between laboratories. Also, partial restriction needs to be carefully evaluated as a potential
source of artefacts. This technique depends therefore, on careful standardization and is
recommended for comparative studies involving few strains rather than for large-scale
epidemiological studies. Given the size of the sequences amplified (1.3Kb for the intragenic
PCR) and the number of (GC rich) copies, the PCR assay requires good quality DNA and
additives like DMSO [21] and thus a careful establishment step.
2.2.3. ITS1 PCR–RFLP and ITS2 targets
Ribosomal RNA (rRNA) genes are highly repetitive and conserved sequences. The ITS1 region
is the sequence in between the 18S rRNA and 5.8S rRNA genes. It has enough conservation to
serve as a PCR target but sufficient polymorphisms to facilitate species typing. ITS1 PCR has
been developed in combination with an RFLP analysis (Table2) with different restriction
enzymes (AluI, BstUI, EcoRI, FspI, HaeIII, HhaI, RsaI, Sau3AI, SphI and TaqI) [16]; HaeIII is the
mostly used restriction enzyme used for species identification. Indeed, ITS1 PCR–RFLP using
HaeIII is the most widely used assay for direct detection and identification of Leishmania species
in the Old World.
It  has been applied for the distinction of  sympatric  species,  especially in the Mediterra‐
nean region [59,60]. However, representatives of the L. donovani complex (L. donovani and
L. infantum) and also of the L. braziliensis complex (L. braziliensis, L. guyanensis, L. panamen‐
sis,  L. peruviana) cannot be distinguished by this approach, even using a great variety of
restriction enzymes [12].  This  limitation can however be bypassed by sequencing of  the
ITS1 PCR product thus allowing for a clear separation of these species and also assign‐
ment of different strains [61].
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Recently, real-time PCR product from the ITS1 region has been used in a high-resolution melt
(HRM) analysis in order to identify and quantify Old World Leishmania species [62]. High
resolution melt analysis is a molecular technique that uses a fluorescent intercalating dye to
measure the rate of double stranded DNA dissociation consequent to an increase of tempera‐
ture. The observed melting curve is characteristic of a particular DNA and depends on its
sequence length, GC content, complementarity, and nearest neighbour thermodynamics. The
dye is incorporated during the amplification; the DNA dissociation measures occur at the end
of the PCR, which is performed in a dedicated thermocycler. The results are computerized and
analyzed through a graphic output. When tested on 300 samples from human cases, reservoir
hosts and sand flies, this approach distinguished all Old World Leishmania species causing
human disease, except L. donovani from L. infantum [62].
The ITS2 region is located in between the 5.8S rRNA and LSU rRNA genes. It has been studied
and found to be adequate for species identification. Indeed, generic PCR primers (LGITSF2/
LGITSR2) were designed to amplify this fragment from Leishmania spp. associated with human
infection, using reference isolates [63] (Table 2). Substantial differences in the ITS2 region
amplified by these primers followed by sequencing analysis, allowed detection of and
discrimination among Leishmania species from the Old and New World [63]. The ITS2 PCR
followed by DNA sequence analysis approach was validated on clinical specimens, which
allowed identification of a total of 8 Leishmania species (L. (V.) braziliensis, L. (V.) guyanensis, L.
(V.) panamensis, L. (L.) mexicana, L. aethiopica, L. major, L. tropica and the L. donovani complex)
among 159 patients corresponding to U.S. civilians that had travel and immigration history to
leishmaniasis endemic countries [63].
The ITS1 and ITS2 region have also been used to assess intra-specific DNA polymorphisms
among L. donovani isolates from different geographical origins [64,65] (Table 2). Single-
stranded conformation polymorphism (SSCP), and sequencing of the ITS regions were applied
to clinical samples of L. donovani from Sudan and one from Kenya, one from India and one
from China. Intra-specific variation in SSCP banding patterns was clearly observed in the ITS1
region and gave five different SSCP profiles; 3 profiles were detected among Sudan isolates
and 2 ITS1-SSCP profiles were observed among the samples from Kenya, India, and China [65].
This corroborates the results of a previous study in which 11 polymorphic ITS1-SSCP patterns
were identified among 63 clinical samples of L. donovani from eastern Sudan [64]. On the other
hand, no variation was observed in the ITS2 region among the 63 studied cases from Sudan
[64] and the study that analyzed the ITS2 locus among 23 Sudanese samples, showed again
the same ITS2 SSCP pattern, with the exception of 1 isolate that had a different one [65].
When the species L. tropica was studied using ITS1 amplification and SSCP analysis, 14 SSCP
profiles within 29 strains from different Old World geographical areas were found [66,67]. The
L. major species was also investigated for DNA polymorphisms using ITS1 and ITS2 PCR
amplification followed by SSCP analysis and sequencing [68]. Results revealed in total five
genotypic variants among L. major isolates from Iran [68].
Recently, authors from Iran used primers LITSR and LITSV to amplify whole ITS region and
found a double banded electrophoretic pattern in L. tropica species, while a sharp single band
was observed for L. infantum and L. major isolates [69]. In order to explain how this two-band
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pattern occur in L. tropica, an in silico analysis of ITS sequences was conducted and showed the
existence of two groups of sequences that differ by a 100bp gap, indicating existence of at least
two alleles for ITS in ribosomal DNA. Thus, a specific reverse primer was developed (LITS-
MG, Table 2) in order to amplify, with LITSR, sequences located just before the gap, which
included ITS1 5.8S and a part of the ITS2 sequence. Amplification using LITS-MG/ LITSR
primer set, followed by sequencing, allowed discriminating L. tropica from L. infantum or L.
major [69].
Although PCR-RFLP of the ITS1 spacer is the most widely used assay for direct detection and
identification of Leishmania species in the Old World, it has some limitations. Despite that all
medically relevant Leishmania species can be distinguished by digesting the ITS1 PCR product
with HaeIII restriction enzyme, representatives of the L. donovani complex (L. donovani and L.
infantum) or L. braziliensis complex (L. braziliensis, L. guyanensis, L. panamensis and L. peruvi‐
ana) have almost identical RFLP patterns with a great variety of restriction enzymes and cannot
be resolved further by this approach [12]. This problem can, however be solved partially by
sequencing the ITS1 PCR product. Use of a highly resolutive agarose or SSCP analysis may be
needed to resolve differences between some species or to investigate intra-specific polymor‐
phism, respectively. ITS2 region has also served for species identification but the drawback of
this approach is the need for DNA sequencing analysis. Sequencing or SSCP analysis may not
be available in most laboratories in areas of endemicity.
2.2.4. hsp70 PCR–RFLP and sequencing
The 70kDa heat-shock proteins (HSP70) are encoded by genes that are highly conserved across
prokaryotes and eukaryotes both in sequence and function. They have great importance as
molecular chaperones in protein folding and transport [70]. Genes encoding cytoplasmic
HSP70s were among the first kinetoplastid genes that were cloned and characterized because
of their conserved nature [71]. HSP70 protein and its encoding gene have been widely used
for phylogenetic and taxonomic studies of different parasites, including Leishmania.
The PCR-RFLP approach targeting hsp70 sequences has proven to be most useful for the
differentiation between South American Leishmania species from the subgenus Viannia
(Table2). Using the restriction enzyme HaeIII to digest the amplified product, the produced
RFLP patterns allowed discrimination between L. guyanensis species complex as well as for L.
lainsoni and L. shawi [22,24]. However, L. braziliensis and L. peruviana, both belonging to the L.
braziliensis complex, as well as L. naiffi showed an identical HaeIII RFLP pattern. They can be
distinguished by using other restriction endonucleases like MboI and BstUI [24]. The Hsp70
PCR-RFLP approach was extended for identification of Old World and additional New World
species with an improved resolution within species complexes; in total 139 strains from 14
species were studied using HaeIII, BccI, RsaI, MluI, and BsaHI restriction enzymes [72]. Two
subsequent digestions of the PCR products identified the species L. infantum and L. donovani
(HaeIII and MluI), L. tropica and L. aethiopica (HaeIII and BsaHI), L. braziliensis and L. peruviana
(HaeIII and RsaI), L. guyanensis and L. panamensis (HaeIII and BccI); the first digestion using
HaeIII discriminates among the broad groups while the additional ones discriminate within
these groups; the species L. major, L. lainsoni and L. naiffi had specific patterns with HaeIII
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restriction enzyme, without need to use an additional digestion [72]. However, it was not
possible to differentiate between the species L. mexicana, L. amazonensis, and L. garnhami [72].
In order to improve the sensitivity and specificity of the previously reported hsp70 PCR,
alternative PCR primers and RFLPs were used [73] (Table2). Thus, three new PCR primer sets
(PCR-F, PCR-N, and PCR-C) and their corresponding restriction scheme (RFLP-F, RFLP-N,
and RFLP-C) were tested. The detection limit of the new PCRs was between 0.05 and 0.5
parasite genomes; they amplified clinical samples more efficiently, and were Leishmania
specific. A specific discriminative power was found for each new RFLP analysis: in general
species from the Old World (L. major, L. tropica, L. aethiopica, L. donovani, L. infantum) and from
the New World (L. infantum, L. lainsoni, L. peruviana, L. guyanensis, L. panamensis) were well
differentiated [73]. Discrimination of L. guyanensis and L. panamensis species, both belonging
to the L. guyanensis complex is important for epidemiological purposes and has also conse‐
quences for the prognosis of the disease, since MCL, which is principally associated with L.
braziliensis, can also be caused by other L. (Viannia) suspected species. Recently, an updated
hsp70PCR RFLP protocol for RFLP-F and RFLP-N designed in [73] was published, with new
restriction enzymes [74]. These new enzymes showed reduced cost and allowed better
separation of some New World (sub)species [74].
Relevance of the hsp70 PCR-RFLP approach [72–74] is illustrated by a study that applied it on
89 clinical samples from a total of 73 Peruvian patients with either cutaneous or mucocutaneous
leishmaniasis. The new PCRs were tested on tissue samples, lesion biopsies, aspirates, and
scrapings. They showed an improved sensitivity both for genus detection and species typing
and identified the species L. braziliensis, L. peruviana and L. guyanensis [75].
In addition to PCR-RFLP analysis, the hsp70 gene was also used in sequencing. Indeed, the
1380bp fragment of the coding region commonly used in RFLP analysis was sequenced in 43
isolates from different geographic origins for studying evolutionary relationships [23]. Fifty-
two hsp70 sequences representing 17 species commonly causing leishmaniasis both in the New
and Old World were analyzed. The authors found that the genus Leishmania formed a mono‐
phyletic group with three distinct subgenera L. (Leishmania), L. (Viannia), and L. (Sauroleish‐
mania). The obtained phylogeny supported the eight species L. (L.) donovani, L. (L.) major, L.
(L.) tropica, L. (L.) mexicana, L. (V.) lainsoni, L. (V.) naiffi, L. (V.) guyanensis and L. (V.) brazilien‐
sis. In some of the species, subspecies L. (L.) donovani infantum, L. (V.) guyanensis panamensis,
and L. (V.) braziliensis peruviana were recognized [23]. Recently, sequencing of the hsp70 gene
was useful for Leishmania species determination within clinical samples, overcoming need for
parasite isolation [76]. The results obtained were in great agreement with those from multilocus
enzyme electrophoresis [76].
The 3’-untranslated region (UTR) of hsp70-type I gene constitutes an alternative target for
sequence analysis [77]. These authors who used it to analyse 24 strains representing 11
Leishmania species, found a remarkable degree of sequence conservation in this region, even
between species of the subgenera Leishmania and Viannia. In addition, the presence of many
microsatellites was a common feature of the 3´-UTR of HSP70-I genes in the Leishmania genus.
Global sequence alignments and resulting dendrograms demonstrated usefulness of this
particular region of hsp70 genes for species (or species complex) typing, improving the
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discrimination capacity of phylogenetic trees based on hsp70 coding sequences in case of some
species (L. donovani/L. infantum; L. tropica and L. aethiopica; L. braziliensis/L. peruviana; L.
guyanensis/L. panamensis) [77].
Using hsp70 gene in PCR followed by RFLP or sequence analysis presents many advantag‐
es.  It  is  easily  comparable  across  all  Leishmania  species  worldwide and discriminates  all
relevant species in both subgenera L. (Leishmania) and L. (Viannia). In addition, the approach
has  been  optimized  for  direct  amplification  from clinical  samples.  However,  systematic
sequencing of the hsp70 gene for Leishmania  identification purposes represents the major
disadvantage of this approach, since this technique needs high-resource settings. For this,
it was stated, “this method is especially suited for use in non-endemic infectious disease
clinics  dealing  with  relatively  few  cases  on  an  annual  basis,  for  which  no  fast  high
throughput diagnostic tests are needed” [76].
2.2.5. Mini-exon PCR-RFLP
The mini-exon genes are involved in the trans-splicing process of nuclear mRNA in kineto‐
plastid protozoa and are present as 100 to 200 tandemly repeated copies per nuclear genome.
Mini-exon genes contain a highly conserved exon of 39 bp with a moderately variable
transcribed intron region (55 to 101 bp) and a highly variable non-transcribed spacer sequence
(51 to 341 bp). These genes were extensively used as a PCR target to identify and discriminate
Old and New World Leishmania species [19,78]. This PCR assay amplified all the miniexon
sequences in a single reaction (Table2). In addition, size variability of the amplification
products allowed preliminary discrimination between the major complexes (Old and New
World Leishmania, and New World Viannia complexes). After enzymatic restriction of the PCR
product with HaeIII or EaeI, a characteristic RFLP pattern is produced that depends on size
variations in the polymorphic spacer regions as well as mutations in the recognition sites of
the restriction enzymes. EaeI profiles were shown to be more informative than HaeIII and
allowed to distinguish between the most important Old World species, L. major, L. tropica, L.
aethiopica, L. infantum and L. donovani [19,78]. However, with HaeIII, species belonging to the
L. braziliensis complex (L. braziliensis and L. peruviana) and to the L. guyanensis complex (L.
guyanensis and L. panamensis) could be discriminated [19].
This genotyping method was successfully applied to naturally infected clinical samples for the
differentiation of New and Old World Leishmania species and showed a high sensitivity and a
robust and reliable species differentiation power [79]. Several other research groups have
applied mini-exon PCR-RFLP method for identification and characterisation of Leishmania
species, using various types of samples from different countries. In [80], they have analyzed
microcapillary cultivated isolates from cutaneous and visceral cases in Turkey and identified
the species L. infantum and L. tropica in CL cases, and L. infantum in VL ones. In Nepal, bone
marrow aspirates from VL patients were analyzed by mini-exon PCR-RFLP and the parasites
have been shown similar to the standard Indian strain of L. donovani and different from the
Kenyan strain [81].
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Recently, mini-exon PCR-RFLP was compared to the ITS1 PCR RFLP approach on a set of
reference strains [82]. The ITS1 PCR proved to be slightly more sensitive and more practical
than the mini-exon. Analysis using the ITS1 digested with HaeIII  allowed to distinguish
most species but an additional digestion with CfoI may be helpful in case of L. mexicana.
However, using the mini-exon, sequencing was found to be the most practical approach as
the mini-exon sequences add information since they are more polymorphic than the ITS1
sequences [82]. Therefore, the mini-exon genes were used for typing the species that belong
to the L. Viannia subgenus, also known as L. braziliensis complex, which cannot be distin‐
guished with the ITS1 [82].
2.2.6. Cysteine protease B (cpb) based PCR and PCR RFLP
Cpb genes are multicopy genes that encode for cathepsin L-like cysteine proteinase B (cpb), a
major antigen of Leishmania parasites.
PCR RFLP assays targeting cpb genes and their non-coding inter-genic sequences were also
developed and applied for characterization of strains from the L. donovani complex [83]
(Table2). The following enzymes were used for intra-genic cpb PCR-RFLP: HinfI, TaaI, HaeIII,
CfrI, HpaII, and SduI, and for inter-genic cpb PCR-RFLP: Eam1104I, NspI, HaeIII, AcyI, and
HaeII [83]. The discriminatory power of this assay was compared with that of PCR-RFLP
analysis of the gp63 gene, and multilocus enzyme electrophoresis (MLEE). Restriction patterns
of the cpb locus were polymorphic, but less so than gp63 patterns and presented differences
with MLEE, supporting a different classification of parasites. The applicability of the devel‐
oped cpb PCR RFLP approach also allowed direct genotyping of parasites in bone marrow
aspirates and blood samples obtained from VL patients in Nepal [83]. This cpb PCR RFLP
approach, in addition to a gp63 PCR-RFLP analysis, were applied to study 59 isolates of the
L. infantum species obtained from different regions in Algeria, originating from various clinical
forms and hosts, and assigned to different zymodemes [84]. Among the four analyzed
zymodemes, 15 different genotypes were obtained. Also, cpb polymorphism showed two
interesting trends: a possible relationship with the cutaneous origin of the isolates and an
association with a West-East cline [84].
Different species–specific PCR assays were developed using these genes as target. PCR assays
discriminating L. donovani from L. infantum were developed [25,26]. An L. donovani species-
specific PCR primer pair amplifies a 317bp at the 3' end of cpb gene of L. donovani whereas it
does not generate an amplicon for L. infantum [26]. Another PCR that was developed based on
cysteine protease B genes differentiates L. infantum from L. donovani by their fragment length:
a 741bp product (cpbF) characterized L. donovani strains, and a 702bp product (cpbE) L.
infantum strains [25]. This primer pair more recently was tested, in addition to a newly designed
one (cpbEF For/L.inf Rev, Table2), on 10 Tunisian L. infantum isolates. The amplification
showed size polymorphism of cpbEF genes with either a 702bp or a 741bp product, even
though the species L. donovani has never been described in Tunisia and the Mediterranean
region [85].
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Five species-specific PCR tests that can discriminate each of the Old World species: L. infan‐
tum, L. donovani, L. tropica, L. aethiopica, and L. major in cultured parasite isolates were also
developed [86] (Table2). All the PCRs are based on the species-specific amplification of the cpb
genes as each primer pair amplifies only one of the different cpb copies present in a particular
species. In addition, the authors established the adaptation of 2 of these assays for oligochro‐
matography detection, which is a rapid dipstick test for visualization of specific amplified L.
infantum and L. donovani products. They concluded to the value of these assays for the
identification of parasites in vitro but the assays were not shown sensitive enough to identify
Leishmania parasites within clinical samples [86].
However, upon sequencing of the cpb- coding region in clinical isolates of L. aethiopica, specific
PCR primers (V5F/V10R) were developed to differentiate this species from L. tropica, L. major,
L. donovani and L. infantum by direct PCR (Table2). This cpb PCR proved to be sensitive enough
to detect L. aethiopica from biopsy samples [87].
Recently, primers developed in [25] were used and new ones were designed, to set up three
species-specific PCR assays based on the amplification of different copies and parts of the cpb
genes (Table2) [85]. They allowed amplification of 1176bp, 600bp and 325bp fragments, thus
discriminating between Old World Tunisian L. major, L. tropica and L. infantum species,
respectively [85].
Multi-copy cpb genes have been recently used to develop a species–specific L. infantum LAMP
assay (Loop-Mediated Isothermal reaction) for the diagnosis of canine leishmaniasis in Tunisia
[88]. This isothermal nucleic acid amplification technique uses intrinsic properties of the
enzyme (Bst DNA polymerase) for auto-strand displacement DNA synthesis to amplify large
amounts of DNA within 30–60 minutes. The amplification reaction that is conducted at only
one temperature does not require a thermocycler and takes profit of the intricate design of a
set of six specific primers [89]. LAMP has emerged as a powerful tool for diagnostics and has
been successfully developed for several protozoan parasitic diseases including leishmaniasis
[90]. Use of cpb genes in the LAMP assay successfully allowed to detect the L. infantum DNA
with a specific amplification, as no cross reaction was seen, with L. major, L. tropica, L. turani‐
ca, L. aethiopica, L. tarentolae, L. gerbilli, Trypanosoma cruzi, or human genomic DNA. In addition,
LAMP assay showed a higher sensitivity when compared to conventional cpb based PCRs [88].
Cpb coding sequence and UTR targets have a proven and good potential to characterize or
identify Leishmania species. Their antigenic nature makes them interesting to describe epide‐
miological features in some areas. However in spite of being multi-copy targets, sensitivity of
their detection seem to be limited likely due to sequence variations underlying the primers
used.
2.2.7. Cytochrome gene sequencing
Cytochromes are involved in the electron transport process of the mitochondrial respiratory
chain. They are considered one of the most useful genes for taxonomy given their slow
evolution rate. They were used for discrimination of Leishmania parasites as well as for
exploring their phylogenetic relationships. Cytochrome oxidase II gene has been first analyzed
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for sequence variation in 22 Leishmania isolates representative of the L. donovani complex from
different geographical origins [91]. Phylogenetic analysis produced maximum parsimony,
neighbor joining and maximum likelihood trees that were congruent and showed two clades
corresponding to the species L. donovani and L. infantum. Furthermore, the molecular haplo‐
types were concordant, in general, with the isoenzyme data of the complex [91]. Interestingly,
L. donovani isolates from Sudan were shown to possess the most ancestral cytochrome oxidase
II sequence with a single haplotype that was very close to that of L. major [91]. The data
provided in this work allowed an approximate dating of the origin of the L. donovani complex
to a period contemporary to or predating the spread of modern humans out of Africa [91].
Cytochrome b (Cyt b) gene has also been used to determine the nucleotide sequence from 13
human-infecting Leishmania species from the New and Old Worlds [92]. The phylogenetic
relationships based on this gene, showed good agreement with the classification of Lainson &
Shaw [93] except for the inclusion of L. major in the L. tropica complex and the placement of L.
tarentolae in another genus [92]. The same group has further applied this method to other
Leishmania species to construct a new phylogenic tree [94]. A total of 30 Leishmania and
Endotrypanum WHO reference strains were analyzed. The phylogenic tree obtained showed
mainly the exclusion of L. major from the L. tropica complex, the placement of L. tarentolae in
the genus and location of L. turanica and L. arabica far from human pathogenic Leishmania
strains [94].
Since that, Cyt b gene have been sequenced in several studies and was shown to be able to
identify the Leishmania species, in Pakistan [95,96], in Colombia [97] and in China [98].
Furthermore, results of Cyt b gene sequencing of 69 cutaneous leishmaniasis cases in Pakistan
showed that only L. tropica was found in highland areas and only L. major in lowland areas [96].
Importantly, among L. major samples analyzed, three types of Cyt b polymorphism were found,
including 45 cases of type I, six of type II and one of type III [96]. The authors reported for the
first time on the presence of polymorphisms in L. major (types I, II and III) based on species
identification using Cyt b gene sequencing from clinical samples [96].
This target is a slow evolving DNA molecule and is thus considered as a good marker for
phylogeny. Being located on the mitochondrial maxicercle, the copy number constitutes
another advantage. Given demonstration of natural genetic exchange experimentally [99] and
naturally [100], these targets known to have a monoparental transmission (also confirmed for
Leishmania) could be ideal for genetic exchange analyses.
2.2.8. Other molecular tools
Several other molecular tools have also been used for identification and characterization of
Leishmania. These include quantitative PCR, AFLP, LAMP assay and others.
In recent years, quantitative PCR methods based either on SYBR Green or TaqMan technology
have been set up for the quantification of Leishmania in different types of biopsies from mice,
dogs and also from human peripheral blood, targeting either single-copy or multi-copy
sequences with high sensitivity and reproducibility [101–104]. In particular, quantitative real
time PCR assays (qPCR) were developed to detect and rapidly differentiate Leishmania species
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and also to quantify parasites within clinical samples. Primers used recognized kinetoplast
minicircle [105,106] and ribosomal DNA [107].
Amplified fragment length polymorphism (AFLP) has also been developed for Leishmania
typing [108]. This technique essentially probes the entire genome at random, without prior
sequence knowledge. Thus, it is ideally suited as a screening tool for molecular markers linked
with biological and clinical traits. It is a PCR-based technique that uses restriction enzymes to
digest DNA, followed by ligation of adapters to the ends of the restriction fragments, which
will be then amplified using specific primers. The amplified fragments are separated and
visualised on denaturing polyacrylamide gels, through autoradiography or fluorescence
methodologies or using automated capillary sequencing instruments. AFLP was adapted to
the Leishmania genome and validated on a panel of samples from the L. donovani complex.
Results were highly congruent with previous analyses using multiple other molecular tests
[109]. AFLPs are particularly useful for assessing genetic variation and genome mapping over
other existing molecular techniques (reviewed in [110]).
Assays using alternative amplification technologies such as quantitative nucleic acid sequence-
based amplification (QT-NASBA) based on amplification of 18S RNA or Loop mediated
isothermal amplification (LAMP) targeting rRNA, kinetoplast DNA or a multigenic family
were also tested on Leishmania infected samples. QT-NASBA yielded a sensitivity of 97.5% and
a specificity of 100% when tested on skin biopsy samples from Old and New World CL patients
[111]. A generic loop mediated isothermal amplification (LAMP) of reverse transcribed
18SRNA had a 83% sensitivity on blood samples of VL patients from Sudan and 98% sensitivity
on skin biopsies of CL patients from Suriname [90]. An L. donovani specific LAMP was
developed targeting kinetoplast minicircle DNA that had 80% sensitivity on 10 blood samples
of VL patients from Bengladesh [112]. This assay evaluated on a larger number of patients
(N=75) and 101 negative controls had 90% sensitivity and 100% specificity; these performances
were found comparable to a nested PCR assay tested on the same samples [113]. An L.
infantum specific LAMP assay, targeting the cysteine protease B multi copy gene was also
recently developed [88]. This tool applied on detection of dog infection in Tunisia had a
sensitivity of 54% and a specificity of 80%, a better performance than the one obtained with a
Cpb PCR assay [88]. LAMP assays constitute promising tools for rapid and sensitive detection
of Leishmania DNA, however for discrimination of Leishmania species and strains other tools
may appear superior at this stage. Their main advantage remains the rapid delivery of results
and the minimal equipment requirement.
3. Strain typing
3.1. Multilocus sequence typing (MLST)
Multilocus sequence typing (MLST) refers to analysis based on the DNA sequence of multiple
gene targets. It is based on the comparison of partial sequences (usually 700 bp) of a defined
set of housekeeping genes. Similarly to MLEE, alleles are scored as identical or not, regardless
of how many different polymorphic loci they have. Strains sharing the same allele combina‐
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tions for the set of genes tested are referred to as sequence types. MLST is able to detect co-
dominant single nucleotide polymorphisms (SNP) and although indels can complicate the
analysis, they are extremely rare in protein-coding genes.
The first Leishmania complex that has been studied with MLST is the L. donovani complex. Two
sets of 5 loci corresponding to genes coding for enzymes used in MLEE were studied: one set
with asat, gpi, nh1, nh2 and pgd and the other one with icd, me, mpi, g6pdh, and fh [7,8].
Results were found to be largely in agreement with the results from MLEE although some key
discrepancies were found and increased resolution was obtained. Thus silent SNPs were found
that provide further resolution, such as a single SNP in gpi that distinguishes between strains
of L. infantum [7]. However, SNPs responsible for amino acid changes were also found in genes
coding for enzymes giving indistinguishable electrophoretic profiles, mainly in nh2, which
had the same protein band for all L. donovani complex strains. MLST study contributed to better
understanding of L. donovani complex phylogeny and taxonomical position of the species L.
infantum and L. donovani [114]. It was a strong argument to question the position of L. archi‐
baldi as a species [6] and existence of MLEE defined L. infantum in Sudan [8]. It also highlighted
potential occurrence of genetic exchange among circulating parasites in East Africa [7,8].
MLST using 6 gene targets that are not associated with MLEE analysis (inorganic pyrophos‐
phatase, spermidine synthase 1, hypoxanthine-guanine phosphoribosyl transferase, mitogen-
activated protein kinase, RNA polymerase II largest sub-unit and adenylate kinase 2) have
been used to characterize suspected L. major/L. infantum hybrids and representative co-
endemic strains in Portugal [115]. Sequence analyses confirmed MLEE hybrid profiles and
hybrid status with occurrence of heterozygous positions in the target genes that so far were
not studied for their diversity within Leishmania species. In a more recent work, 2 of these genes
and 5 others (Elongation initiation factor 2 alpha subunit, zinc binding dehydrogenase-like
protein, translation initiation factor alpha subunit, nucleoside hydrolase-like protein and a
hypothetical protein located on chromosome 31) were analyzed on a panel of 222 strains
representative of 10 different species in 43 countries in Eurasia and Africa, corresponding to
110 zymodemes with the objective to study the genetic diversity of the genus Leishmania,
improving our knowledge on the genetic structure and genomic evolution mechanisms of this
genus [116]. Seven genetically robust clusters were obtained that overlapped with most of the
biochemical taxonomy groups: clusters I, III, IV, V and VI included strains belonging to the
MLEE-based species L. aethiopica, L. arabica, L. turanica, L. gerbilli and L. major, respectively and
cluster II included the L. tropica and L. killicki strains; with the exception of the species that
cause forms of visceral leishmaniasis (cluster VII that comprised strains from L. donovani, L.
infantum and L. archibaldi) in line with the concept of species complex suggested for this group.
No observations were made of interspecific recombination or genetic exchange between the
different species but these strains were selected for the study as not resulting from a likely
genetic exchange [116]. It is anticipated to observe more informative studies increasing the
number of markers or the strains circulating within selected endemic areas notably that co-
sympatry of multiple parasite species is a well-established feature in many endemic areas.
In the New World, four housekeeping genes (glucose-6-phosphate dehydrogenase (G6PD), 6-
phosphogluconate dehydrogenase (6PGD), mannose phosphate isomerase (MPI) and isoci‐
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trate dehydrogenase (ICD)) were sequenced from 96 Leishmania (Viannia) strains that were
chosen to be representative of the zymodeme and geographical species diversity of this
subgenus, in South America, and in particular Brazil, in order to assess their discriminatory
typing capacity and refine phylogeny of the L. (Viannia) species [117]. A large number of
haplotypes were detected for each marker. Maximum parsimony-based haplotype networks
showed separated clusters in each network, corresponding to strains of different species,
congruent with the MLEE identification. Besides, NeighborNet formed by the concatenated
sequences confirmed species-specific clusters. This analysis also suggested recombination
occurring in L. braziliensis and L. guyanensis. However, using phylogenetic analysis, the species
L. lainsoni and L. naiffi were shown to be the most divergent species and placed the L. shawi
species in the L. guyanensis cluster, not as a distinct species. The authors also found the L.
braziliensis strains to correspond to one widely geographically distributed clonal complex in
Brazil and another restricted to one endemic area, in a region bordering Peru [117].
The main advantage of MLST is the possibility of generating genus-wide phylogenies, since
MLST markers are co-dominant and are amenable for population and phylogenetic analyses.
Also, given the high quality of sequence data, results can be easily compared between
laboratories. Compared to MLEE, MLST does not necessarily require sterile culture of
parasites. In addition, simultaneous typing of reference strains and sequencing can be done
commercially without in-house specialized equipment. For those reasons, MLST is likely to
become the gold standard basis for taxonomy and thus identification of Leishmania. One
expected drawback could be the inherent limit of detection of nucleotide allelic diversity
associated to direct sequencing of PCR products, which could be overcome by more lengthy
analyses like cloning of parasites or PCR products. One consequence of this drawback is that
MLST should not be considered as typing tool but an analysis tool. Another application could
be diagnosis as recently new species-specific genetic polymorphisms were identified in the
genes that confer the phenotypic variations in the MLEE assay [118]. Indeed, sequencing of
the MPI and 6PGD genes was sufficient to differentiate among closely related species causing
New World leishmaniasis, in Peru. The same group took advantage of these polymorphisms
and designed a new real-time PCR assay based on FRET (fluorescence resonance energy
transfer) technology and melting curve analysis using SYBR green. The assay was highly
sensitive and correctly identified each of the five main species that cause tegumentary
leishmaniasis in the New World, directly from clinical samples [119].
3.2. Multilocus microsatellite typing (MLMT)
Microsatellites are repeated motives of 1–6 nucleotide(s), which present allelic length variation.
They mutate fast, therefore, 10–20 independent markers have to be analyzed for each strain
owing to homoplasy. Microsatellite sequence variation results from the gain and loss of repeat
units, which can easily be detected after amplification with specific primers annealing to their
flanking regions. Then length polymorphisms are detected using PAGE, MetaPhor agarose
gel electrophoresis or, preferably, automated capillary sequencers. A multilocus microsatellite
profile is compiled for each sample from the fragment length measured for the microsatellite
markers analyzed.
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During the last years, microsatellite-based approaches have been developed for strain typing
within the genus Leishmania to overcome the lack of discriminatory power of MLEE and other
molecular tools. So far, microsatellite loci with high discriminatory power and suitable for
characterizing closely related strains have been published for the L. donovani/L. infantum
complex [120–122], L. major [123,124], L. tropica [125] and for species of the subgenus L.
(Viannia) [126–128].
3.2.1. Subgenus L. Leishmania
3.2.1.1. L. donovani complex
Within the L. donovani complex, a set of 15 microsatellite markers have been applied to type
strains of L. donovani and L. infantum isolated from the main endemic regions for VL (India,
East Africa, Mediterranean region, Asia and South America) [129]. Six principal genetically
distinct populations were identified: 2 populations of L. infantum from the Mediterranean area
and South America comprising the MON-1 and non-MON-1 strains, respectively; 2 popula‐
tions of L. donovani from Sudan and Ethiopia; 1 of L. donovani MON-2 from India; and 1
consisting of strains of L. donovani (MON-36, 37 and 38) from Kenya and India. These results
corroborated the fragmentary data published in numerous studies using other genetic
markers. Interestingly, the highest microsatellite diversity was observed for L. infantum from
the Mediterranean basin and the lowest for L. donovani from India. Using 34 additional
microsatellite sequences, analysis showed the homogeneity of L. donovani from the Indian
subcontinent [130].
Different genetic groups of strains of L. infantum were also observed when strains from Algeria,
Tunisia, the Palestinian Authority and Israel were subjected to MLMT. Microsatellite typing
of strains belonging to zymodemes MON-1, MON-24 and MON-80 identified 3 different
populations in Algeria and in Tunisia [131,132]. The MON-1 strains were assigned to 2 different
populations one of which contained only local strains and the other local and European strains
of MON-1. The non-MON-1 strains were always separated from the MON-1 ones. Gene flow
was detected between the two MON-1 populations and the local MON-1 and the non-MON-1
populations, respectively [131,132]. L. infantum Israeli and Palestinian strains obtained from
infected dogs and human cases showed 2 main populations genetically different from
European populations, one of which is sub-divided in geographically distributed sub popu‐
lations [133].
In Spain, L. infantum strains from a rural leishmaniasis-endemic area, from which 94 were
obtained from dogs, 15 from sand flies, and 1 from a human visceral case, were MLMT studied
[134]. Results showed existence of 17 genotypes that were detected using 10 microsatellite
markers belonging to 3 different targets. They also showed the heterogeneous distribution of
L. infantum species in hosts living in sympatric conditions.
Analysis of L. infantum strains having a New World origin by MLMT indicated that these
strains were more similar to MON-1 and non-MON-1 sub-populations of L. infantum from
southwest Europe, than to any other Old World sub-population [135] thus indicating that the
parasite has been recently imported multiple times to the New World from southwest Europe.
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Within the L. donovani complex, L. donovani, L. infantum and L. archibaldi strains from Sudan
were studied by MLMT technique [6]. The authors found one single monophyletic L. donova‐
ni clade and argued that the isoenzyme differentiation of L. donovani and L. infantum in East
Africa was misleading and that L. archibaldi is an invalid taxon [6].
Analysis of L. donovani strains from India, Bangladesh, Sri Lanka and Nepal showed that in
Sri Lanka the causative agent of CL is most closely related to parasites causing VL in India
[136] and that genetically homogeneous strains are circulating in the Indian subcontinent [130].
On the other hand, L. donovani strains belonging to the MON-37 zymodeme and originating
from different geographical origins (India, Sri Lanka, Middle East, Cyprus and East Africa)
were MLMT analyzed [9]. Zymodeme MON-37 was found to be paraphyletic, representing
different genetic groups corresponding to their geographical origin and strains from Cyprus
were clearly different from all others and could be autochthonous [9].
3.2.1.2. L. tropica
MLMT technique was also applied for L. tropica strain typing. Indeed, 117 strains from Asia
and Africa were used and revealed 10 genetic groups, which were largely correlated to the
geographical origin of the strains [125]. Different genetic groups were shown to co-exist in
strains from the Middle East and Morocco. However, the authors postulated that recent spread
of new genotypes has occurred recently in the Middle East and suspected an African origin of
the L. tropica species [125].
3.2.1.3. L. major
Concerning L. major, 106 strains from Central Asia, Africa and the Middle East were analyzed
using MLMT, based on 10 different microsatellite markers [124]. The study showed three main
populations corresponding to the three geographical regions studied that were further
subdivided into 2 sub-populations. Interestingly, the African and Middle Eastern populations
seemed to be more genetically diversified than the Central Asian population [124].
3.2.2. Subgenus L. Viannia
Within the New World L. Viannia subgenus, the first MLMT studied species were L. brazilien‐
sis and L. peruviana. Fifty- nine analyzed Peruvian strains showed emergence of multiple L.
braziliensis/L. peruviana hybrids [137]. Then, 124 L. braziliensis strains from Peru and Bolivia
were investigated for their genetic polymorphism at 12 microsatellite loci [127,138]. A sub‐
stantial genetic diversity with high levels of inbreeding, inconsistent with a strictly clonal
reproduction was shown. Besides, a large genetic heterogeneity between populations within
countries was described, which evidenced a strong population structure at a microgeographic
scale [138].
In another study, polymorphisms of 30 strains of L. braziliensis, 21 strains of L. guyanensis, and
2 strains of L. peruviana from Brazil, Paraguay and Peru were analyzed at 15 independent
microsatellite loci [128]. All strains except two L. guyanensis had individual MLMT types. In
addition, three main clades were found, that consisted of one population of strains of L.
Leishmaniasis - Trends in Epidemiology, Diagnosis and Treatment84
guyanensis only, another one with strains of L. braziliensis from Paraguay and Brazil, and the
last one with strains of L. braziliensis and L. peruviana [128].
Recently, 28 strains of the main species of the L. guyanensis complex (L. guyanensis and L.
panamensis), collected in Ecuador and Peru were investigated in an MLMT study, with 12
microsatellite markers [139]. An important heterozygote deficit was observed in these
populations, similar to the previously reported results in L. braziliensis complex [138]. They
further showed genetic polymorphism and geographical differentiation on the L. guyanensis
complex [139].
All together, these studies confirmed that microsatellite markers constitute good tools for
typing and population genetic studies of Leishmania. Their additional advantage resides in the
possibility of their use directly in biological material without culturing of parasites [130,140].
Moreover, accurate, quality controlled microsatellite profiles could be stored in databases and
compared between different laboratories.
4. Leishmania parasite evolution, genetics and genome analyses –
Consequences and prospects
For many years Leishmania parasites have been considered to replicate clonally, without genetic
exchange. Indeed, Tibayrenc proposed that clonal evolution in micropathogens be defined as
restrained recombination on an evolutionary scale, with genetic exchange scarce enough to
not break the prevalent pattern of clonal population structure (Reviewed in [141,142]). The two
main manifestations of clonal evolution are strong linkage disequilibrium (LD) and wide‐
spread genetic clustering ("near-clading"). These authors hypothesized that this pattern is not
mainly due to natural selection, but would originate chiefly from in-built genetic properties
of pathogens, that would allow like for other microorganisms (viruses, bacteria, protozoan
parasites) to keep a balance between clonality and recombination, which would help escape
from recombinational load. This way, to face evolutionary challenges, pathogens would be
equipped with “clonality/sexuality machinery” that would function as alternative allelic
systems [141,142]. However, an accumulation of molecular evidence indicates that there are
inter-specific [115,137,143–146] and intra-specific [132,138] hybrids among natural popula‐
tions. Genetic exchange was finally demonstrated experimentally in 2009 [99]. In fact, double
drug resistant Leishmania major hybrids were produced by co-infecting Phlebotomus duboscqi
(a natural L. major vector) sand flies with two strains carrying different drug resistance markers.
The nuclear genotypes were consistent with a Mendelian transmission leading to a heterozy‐
gous first generation progeny [99]. The anticipated continuity of these studies was to co-infect
sand flies with transgenic Leishmania carrying two different markers that are fluorescent, in an
attempt to visualize the recombination events microscopically [147]. In 2011, for the first time,
using a fluorescent protein detection system to observe yellow hybrid promastigotes in
Phlebotomus perniciosus and Lutzomyia longipalpis midguts, L. donovani hybrids were observed,
2 days post bloodmeal, and the morphological stages involved were found to be short procyclic
promastigotes [100]. However, the parasites could not be recovered and propagated to confirm
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their hybrid genotypes [100]. Recently, the analysis of the mating competency of L. major strains
have been expanded to include pairwise matings of multiple isolates bearing independent
drug markers [148]. Also, the timing of the appearance of hybrids and their developmental
stage associations within both natural (Phlebotomus duboscqi) and unnatural (Lutzomyia
longipalpis) sand fly vectors was followed. Genotype analysis of a large number of progeny
clones showed a chromosomal inheritance of both parental alleles at 4–6 unlinked nuclear loci,
consistent with a meiotic process, and a uniparental inheritance of kinetoplast DNA [148]. A
low frequency of nuclear loci showed only one parental allele, suggesting loss of heterozygos‐
ity, most likely arising from aneuploidy, which is common in Leishmania. In the natural vector,
when comparing the timing of hybrid formation and the presence of developmental stages,
the authors suggested that nectomonad promastigotes are the most likely mating competent
forms, with hybrids emerging before the first appearance of metacyclic promastigotes [148].
MLMT analysis showed that recombination events are much more frequent in Leishmania than
previously thought. Indeed, MLMT analysis of Bolivian and Peruvian L. braziliensis showed
frequent sexual crosses of individuals from the same strain (inbreeding) [138]. The substantial
heterozygote deficiency and extreme inbreeding found in this study is not consistent with a
strictly clonal reproduction. The authors came to the conclusion that Leishmania parasites may
alternate between clonal and sexual modes of reproduction, occurring most probably in the
vector [138]. Sexual fusion may frequently take place between genetically related parasites or
even within the same strain with occasional recombination events between individuals of
different genotypes.
Also, L. braziliensis/L. peruviana hybrids were found to be quite common in a Peruvian focus
where both species can occur sympatrically [137]. In the Old World, natural L. infantum/L.
major hybrids were experimentally transmitted by Ph. papatasi, usually only competent to
transmit L. major [149]. This suggests that hybrids may circulate using this sand fly vector and
spread into new foci throughout the broad range of Ph. papatasi distribution.
The fact that Leishmania can undergo genetic exchange is potentially of profound epidemio‐
logical significance since this could facilitate the emergence and spread of new genotypes and
phenotypic traits. Also, hybrid offspring might show a strong selective advantage relative to
the parental strains. In [149], the authors have shown that natural hybrids could have enhanced
transmission potential and a positively affected fitness.
New high-throughput sequencing technologies have opened the door for population genome
analyses and genome-wide association studies. Genome of the L. major species was the first to
be fully sequenced [150] followed by L. infantum and L. braziliensis [151]. Comparison of the
three genomes revealed conservation of synteny and identified only 200 genes having a
differential distribution between the three species. Such genes may encode for proteins
implicated in host-pathogen interactions and parasite survival in the macrophage [151]. The
species L. mexicana and L. donovani were subsequently sequenced [152,153] and the reference
genomes for L. major, L. infantum, and L. braziliensis were refined [152]. This has allowed the
identification of a remarkably low number of genes or paralog groups unique to each of the
species L. mexicana, L. major, L. infantum, and L. braziliensis (2, 14, 19, and 67, respectively).
Besides, L. major and L. infantum were found to have a surprisingly low number of predicted
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heterozygous SNPs compared with L. braziliensis and L. mexicana. Chromosome copy number
also varied significantly between species, with nine supernumerary chromosomes in L.
infantum, four in L. mexicana, two in L. braziliensis, and one in L. major. The authors also showed
that gene duplication events occur more frequently on disomic chromosomes [152]. In addition
to sequencing of an L. donovani reference genome, a recent study also included sequence
analysis of a set of 16 related clinical lines, isolated from VL patients in Nepal and India, which
also differ in their in vitro drug response [153]. Sequence comparisons with other Leishmania
species and analysis of single-nucleotide diversity showed evidence of selection acting on
different surface- and transport-related genes, including genes associated with drug resistance.
Extensive variation in chromosome copy number between the analyzed lines was also shown.
In association to drug resistance, they also showed structural variation, including gene dosage
and copy number variation of a circular episome, present in all lines [153].
Genomic research on Leishmania is taking promising directions, mainly upon sequencing of
the main pathogenic species [150–153] and also the non pathogenic L. tarentolae [154] which
will enable to answer key questions on population genetics and ultimately unravel many
important aspects related to drug resistance and virulence, which are especially relevant for
control of the disease.
Novel genomics technologies are expected to bring more powerful tools to characterize the
pathogens and particularly the infectious stages of Leishmania parasites. It will be particularly
useful to fully characterize the parasites within the lesions/hosts in their microenvironment.
While so far expression profiling relied mainly on microarray analysis which revealed only a
limited number of differentially expressed genes across developmental stages [155], or species
[156]. RNA sequencing technology seems very promising to highlight transcriptional events
that are associated to parasite life cycle, infection or pathology. Previous studies have dem‐
onstrated a correlation between gene expression and gene copy number [157,158]. It was
further hypothesized that “Increased gene copy number due to chromosome amplification
may contribute to alterations in gene expression in response to environmental conditions in
the host, providing a genetic basis for disease tropism” [152]. Other studies have also suggested
that Leishmania parasites do not respond dynamically to host immune pressure, and that any
influence of varying transcript levels on virulence and pathogenicity of the different Leishma‐
nia species is likely to result from the differential expression of conserved genes between
species and/or the expression of a small number of genes that are differentially distributed
between species [159].
Genome-wide multilocus genotyping in malaria research through novel sequencing technol‐
ogies has allowed the identification of almost 47000 single nucleotide polymorphisms (SNPs)
across the Plasmodium genome [160]. This allowed development of microarray–based plat‐
forms for screening more than 3000 SNPs that were successfully applied for population genetic
analyses and genome-wide association studies in P. falciparum [161,162]. Similar studies still
need to be developed for Leishmania.
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5. Conclusion
Epidemiological, taxonomic and population genetic studies of Leishmania require good
sampling methods and appropriate molecular markers that allow discrimination at different
levels. Answering key epidemiological questions requires new or improved tools that allow
discrimination of Leishmania parasites at different levels. The MLEE, considered as gold
standard technique, needs cultured parasites and lacks discriminatory power. PCR assays are
likely to replace isoenzyme analysis since they enable direct detection and identification of
different Leishmania species in human and animal samples and also in infected sand flies. Many
of the PCR assays described in the literature have proven useful in numerous field studies.
However, they still need to be standardized and validated as diagnostic PCR assays and
comparisons of the sensitivity and specificity parameters of the different approaches need also
validation under routine conditions. In general, more than one assay is necessary to obtain
fully satisfactory analysis of field samples. Given emergence context and changing eco-
epidemiological trends, multiple tools will be needed to fully investigate the transmitted
parasites.
At the strain level differentiation, MLMT has potential for being a gold standard, because on
its principle it is expected to be reproducible and brings possibility of data storage and
exchange. However, microsatellite markers are largely species-specific in Leishmania and
different marker sets have to be used according to species. Such databases do not exist yet and
data generation will need standardization. It may also require access to automated sequencers
and good knowledge of population genetics programs. On the other hand MLST appears
potentially as more powerful for phylogenetic and evolutionary studies although less dis‐
criminatory than MLMT. It is most probably this technique that will advantageously replace
MLEE in the future. Some results showed that the same targets could be used across the
Leishmania genus, which will enable comparisons of distances between the species but also of
the degree of genetic diversity within species [163]. Here also it will require access to automated
sequencers and adequate analytical programs. Cost of both approaches are relatively high and
inherent limitations will be most likely overcome by the next generation sequencing ap‐
proaches expected to gain momentum in a near future. Leishmania population genomics still
needs to be developed and made accessible to researchers in disease endemic countries to best
achieve its public health potential.
Parasite knowledge is so far built on strains obtained in vitro. Increasing interest in Leishma‐
nia parasite analyses will likely identify novel genotypes or organisms, a challenge for our
current knowledge on parasite taxonomy and assays to identify and characterize parasites.
Improving ways to enhance knowledge on parasites within samples remains a priority.
In spite of the increasing potential of sophisticated technologies and techniques, some disease
endemic areas still need simple assays for eco-epidemiological investigations or diagnosis as
well as capacity building in this highly relevant area to disease control.
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